Exactly. Without some extremely robust data, I would not want to administer any kind of immunosuppressant to a patient infected with COVID-19. My gut instinct is that the harm would outweigh the benefits.
Well we would need to have clear metrics for cases in which that would harm vs help. And we don't have those biomarkers yet. I suspect we will at some point though.